Please find enclosed Notice of Separate Meeting of Independent Directors of the Company
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Limited) has informed the BSE about a separate meeting of its Independent Directors scheduled for 25th March 2026 at 11:00 A.M. at the corporate office in New Delhi. The meeting is being held as required under SEBI LODR Regulation 25(3) and Schedule IV of the Companies Act, 2013. The agenda includes reviewing the performance of non-Independent Directors and the Board as a whole, and assessing the quality and timeliness of information flow between management and the Board. This is a routine corporate governance compliance filing and does not involve any financial or business decision.
This is a routine governance filing with no direct impact on shareholders or the stock price. It is a standard regulatory requirement that all listed companies must follow.